Fortress Biotech, Inc. (FBIO)

Fortress Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	44	27	71	249	297	182
Market Cap Growth	-63.85%	-62.16%	-71.44%	-16.15%	63.29%	273.18%
Enterprise Value	44	29	11	8	138	144
PE Ratio	-	-0.39	-0.75	-3.85	-6.38	-4.55
PS Ratio	0.52	0.32	0.94	3.62	6.51	4.97
PB Ratio	1.91	1.19	1.71	2.29	2.96	6.94
P/FCF Ratio	-0.37	-0.22	-0.39	-2.05	-3.42	-1.82
P/OCF Ratio	-0.35	-0.21	-0.40	-2.14	-3.55	-1.92
EV/Sales Ratio	0.51	0.34	0.14	0.12	3.04	3.92
EV/EBITDA Ratio	-1.20	-0.79	-0.17	-0.18	-5.10	-5.83
EV/EBIT Ratio	-0.95	-0.65	-0.15	-0.16	-4.46	-5.11
EV/FCF Ratio	-0.37	-0.24	-0.06	-0.07	-1.60	-1.44
Debt / Equity Ratio	3.72	3.80	2.89	0.62	0.76	4.39
Debt / EBITDA Ratio	-2.68	-2.33	-1.91	-1.50	-2.81	-4.67
Debt / FCF Ratio	-0.82	-0.70	-0.66	-0.55	-0.88	-1.15
Quick Ratio	1.09	1.16	1.64	3.28	5.02	3.68
Current Ratio	1.33	1.38	1.80	3.43	5.14	3.43
Asset Turnover	0.51	0.44	0.22	0.17	0.16	0.17
Interest Coverage	-2.96	-2.93	-5.31	-3.20	-2.03	-2.37
Return on Equity (ROE)	-311.30%	-287.50%	-135.90%	-62.30%	-63.10%	-152.70%
Return on Assets (ROA)	-37.90%	-36.00%	-27.20%	-16.00%	-16.50%	-18.30%
Return on Capital (ROIC)	-110.45%	-131.63%	-125.29%	-107.42%	-53.33%	-78.40%
Earnings Yield	-143.22%	-255.11%	-132.98%	-25.98%	-15.66%	-21.97%
FCF Yield	-238.01%	-454.30%	-255.81%	-48.78%	-29.22%	-54.81%
Buyback Yield / Dilution	-152.52%	-36.89%	-8.78%	-13.46%	-31.61%	-25.88%
Total Shareholder Return	-152.52%	-36.89%	-8.78%	-13.46%	-31.61%	-25.88%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).